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Abstract The possible beneficial role of selenium (Se) on the
oxidative stress induced by lead (Pb) is still unclear in
humans. Therefore, the aim of the present study was to ex-
plore the associations among the Se levels, chronic Pb expo-
sure, oxidative stress parameters, and parameters characteriz-
ing the function of the antioxidant defense system in men who
are occupationally exposed to Pb. Based on the median serum
Se concentrations, the 324 study subjects were divided into
two subgroups: a subgroup with a low Se level (L-Se) and a
subgroup with a high Se level (H-Se). The levels of lead (PbB)
and zinc protoporphyrin (ZPP) in the blood and the delta-
aminolevulinic acid (ALA) level in the urine served as indices
of Pb exposure. The PbB level was significantly lower in the
H-Se group compared to that in the L-Se group by 6 %. The
levels of 8-hydroxyguanosine and lipofuscin (LPS) and the
activity of superoxide dismutase were significantly lower in
the H-Se group compared to that in the L-Se group by 17, 19,
and 11 %, respectively. However, the glutathione level (GSH)
and the activities of glutathione peroxidase (GPx) and catalase
were significantly higher by 9, 23, and 3 %. Spearman corre-
lations showed positive associations between the Se level and
GPx activity and GSH level. A lower serum Se level in chron-
ically Pb-exposed subjects is associated with higher Pb blood
levels and an elevated erythrocyte LPS level, which reflects
the intensity of oxidative stress. Besides, in a group of Pb-
exposed subjects with lower serum Se level, depleted GSH
pool and decreased activity of GPx in erythrocytes were re-
ported. However, the present results are inadequate to recom-
mend Se supplementation for chronic lead exposure at higher
doses than would be included in a normal diet except for
selenium deficiency.
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Introduction
Exposure to lead (Pb) is still a major concern for humans
worldwide. Exposure to Pb appears from contact with Pb-
based paints, automobiles, batteries, and other sources [1, 2].
The respiratory and gastrointestinal tracts are the principal
routes that permit Pb to enter the human body. Pb accumulates
in the blood, soft tissues, and bones [3]. According to the
newest researches, no safe level of exposure to Pb has been
found [4]. The symptoms of the early stages of inorganic Pb
exposure include a loss of appetite, weight loss, fatigue, irri-
tability, occasional vomiting, and anemia, whereas at high
levels, exposure to Pb causes kidney damage, behavioral dis-
turbances, anemia, hypertension, and toxicity to the reproduc-
tive system [1, 2].
The toxicity of Pb is largely due to its ability to induce an
imbalance in the generation and removal of reactive oxygen
species (ROS) in tissue and cellular components, generally
called oxidative stress [5]. On the one hand, the presence of
Pb may increase the generation of ROS [6, 7]. On the other
hand, Pb depletes the antioxidant defenses, such as glutathi-
one (GSH) and modifies activities and expression of antioxi-
dant enzymes, such as superoxide dismutase or glutathione
peroxidase (GPx) [8, 9]. Therefore, exposure to Pb results in
* Sławomir Kasperczyk
kaslav@mp.pl
1 Institute of Occupational Medicine and Environmental Health,
Poland, 41-200 Sosnowiec, Poland
2 Department of Biochemistry, School of Medicine with the Division
of Dentistry in Zabrze, Medical University of Silesia, Katowice,
Jordana 19, 41-808 Zabrze, Poland
Biol Trace Elem Res (2016) 170:1–8
DOI 10.1007/s12011-015-0435-z
the oxidative damage to lipids, DNA, and proteins [5]. The
toxic action of Pb is also related to its inhibitory effect on
delta-aminolevulinic acid dehydratase (ALAD) and
ferrochelatase. Consequently, Pb exposure impairs the chain
reaction that leads to the formation of heme and results in the
accumulation of delta-aminolevulinic acid (ALA), which has
pro-oxidative and alkylating properties [5, 6].
It has been well established that Pb interacts and competes
with other cations [10]. Among them is selenium (Se). Se is a
non-metal element that has been linked to many health bene-
fits in humans and other mammals such as decreasing the
incidence of cancer, protecting against cardiovascular dis-
eases, and treating certain muscle disorders. Besides, Se is
involved in mammalian development, boosting immune func-
tion, tissue respiration, and antioxidant defense [1, 11, 12]. Se
is a cofactor for GPx, an antioxidant enzyme, which utilizes
hydrogen peroxide to convert reduced glutathione to its oxi-
dized form (GSSG). It has been demonstrated that
selenoproteins, through their antioxidant properties, help to
eliminate reactive oxygen species induced by metals [1].
The results of several animal studies have shown that Se or
the combination of Se and other antioxidants can reduce Pb-
induced oxidative stress. On the other hand, the possible ben-
eficial role of Se alone on Pb-induced oxidative stress is still
unclear in humans [5].
The current therapeutic approach to Pb poisoning is to in-
crease its excretion by chelation. Chelators have been shown
to reduce blood Pb levels; however, their safety and efficacy
may be questioned. Consequently, it is necessary to find new
agents capable of abating toxic effects of Pb [13]. In light of
this, Se supplementation may be considered as a potential
therapy for chronic Pb poisoning due to the antioxidant prop-
erties of Se. However, too little is known about possible inter-
actions between Pb and Se. Therefore, the aim of the present
study was to explore the associations among the Se levels,
chronic Pb exposure, oxidative stress parameters, and param-
eters characterizing the function of the antioxidant defense
system in men who were occupationally exposed to Pb.
Materials and Methods
Study Population
The exposed population consisted of 324 occupationally Pb-
exposed males who had given informed consent for their par-
ticipation in this study. All of the study subjects were
employed in the zinc and Pb works in the southern region of
Poland. They lived near the workplace and had a similar so-
cioeconomic status. The mean concentration of Pb in the air at
participants’ workplaces was 0.083 ± 0.12 mg/m3. This mean
concentration exceeds the Polish MAC level of 0.050 mg/m3
[14]. Besides, examined subjects were exposed to negligible
doses of zinc. The mean concentration of zinc in the air at
participants’ workplaces was 0.15 ± 0.13 mg/m3. This value
is much lower than the Polish MAC level of 5.0 mg/m3. Ex-
amined subjects were not occupationally exposed to selenium.
All participants continued to work during the study.
Based on the median serum Se concentrations, the subjects
were divided into two subgroups: a subgroup with a low Se
level (L-Se) and a subgroup with a high Se level (H-Se).
Questionnaire data on age, weight, height, medical history,
and smoking habits were obtained. Moreover, blood pressure
was measured in all of the study subjects. The study was
approved by the Bioethics Committee of the Institute of Oc-
cupational Medicine and Environmental Health, Sosnowiec,
Poland.
The levels of Pb (PbB) and zinc protoporphyrin (ZPP) in
the blood and the ALA level in the urine served as short-term
lead-exposure indices. To determine the long-term Pb expo-
sure, the concentrations of Pb and ZPP in the blood samples
were determined, on average, every 3 months during the
5 years of observation. From the collected data, the mean
blood concentrations of Pb (PbBmean) and ZPP (ZPPmean)
were calculated.
Sampling and Laboratory Procedures
Two samples of blood were obtained from the cubital vein into
vacuum tubes (Vacuette®, Greiner-Bio, Frickhausen, Germa-
ny) containing K3EDTA for whole blood analyses and plain
tubes for serum analyses. Blood samples were frozen and
stored at −20 °C until the analyses were performed. Mid-
stream morning urine was collected to measure ALA levels.
To measure the ALA and 8-hydroxydeoxyguanosine (8-
OHdG) levels, urine was collected on the same day as blood.
The assessments of the PbB and serum Se concentrations were
performed by graphite furnace atomic absorption spectrome-
try [15, 16] using an ICE 3400 instrument (Thermo Fisher
Scientific Waltham, MA, USA). The laboratory met the re-
quirements of proficiency tests (Lead and Multielement Pro-
ficiency—CDC in Atlanta). The ClinCal® Whole Blood Cal-
ibrator and ClinCal® Serum Calibrator (Recipe, Germany)
were used for calibration of the instrument and control mate-
rials. ClinCheck Whole Blood Control Levels I, II, and III and
ClinCheck Serum Control Levels I and II were used for quality
control. The results were expressed as micrograms per deciliter
(Pb) and micrograms per liter (Se). The level of ZPP was
measured using an Aviv Biochemical hematofluorometer,
model 206. The results were expressed as micrograms per
gram of hemoglobin (Hb). The concentration of Hb was deter-
mined using the cyanmethemoglobin method.
The level of ALAwas estimated spectrophotometrically in
urine samples by the method described byGrabecki et al. [17].
The results were expressed as milligrams per deciliter. The 8-
OHdG level was measured in urine using a commercially
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available ELISA-based assay (Cat. RSCN213100R,
BioVendor) according to the manufacturer’s instructions.
Spectrophotometric readings were obtained using a BIO-
TEK Eon microplate reader (BIO-TEK Instruments), and the
results were expressed as grams of creatinine in urine.
The levels of serum malondialdehyde (MDA) were deter-
mined according to the method described by Ohkawa et al.
[18]. The results were recorded as micromoles per liter. The
method developed by Södergren et al. [19] was used to mea-
sure the concentrations of lipid hydroperoxides (LPH) in the
serum. The results were recorded as micromoles per liter. The
levels of lipofuscin (LPS) in erythrocytes were measured ac-
cording to the Jain [20] method. The results were expressed as
relative units (RU) per gram of hemoglobin (the fluorescence
of a 0.1 mg/ml solution of quinidine sulfate in sulfuric acid is
equal to 100 RU). The total oxidant status (TOS) was mea-
sured in serum according to the method described by Erel
[21]. The data were shown in micromoles per liter.
The total antioxidant capacity (TAC) in millimoles per liter
was measured according to the report by Erel [22]. The levels
of erythrocyte glutathione (GSH) were measured as described
by Pawelski [23]. The obtained concentrations were expressed
as micromoles per gram of Hb (μmol/g Hb). Oyanagui’s
method [24] was used to measure the activity of superoxide
dismutase (SOD) in erythrocytes. The enzymatic activity of
SOD was expressed in nitric units. The activity of SOD is
equal to 1 nitric unit (NU) when it inhibits nitric ion
production by 50 %. The activities of SOD were normalized
to milligrams of Hb (NU/mg Hb). The catalase (CAT) in
erythrocytes was measured by the Aebi [25] kinetic method.
Catalase activity was expressed as international units per mil-
ligram of Hb (IU/mg Hb). The erythrocyte glutathione perox-
idase (GPx) activity was measured by the kinetic method de-
scribed by Paglia and Valentine [26]. The activity of GPx was
expressed as micromoles of NADPH oxidized per minute
normalized to grams of Hb (IU/g Hb). The activity of gluta-
thione reductase (GR) in erythrocytes was measured accord-
ing to the report by Richterich [27]. The activity of GR was
expressed as micromoles of NADPH utilized per minute nor-
malized to 1 gram of Hb (IU/g Hb).
Statistical Analysis
The statistical analysis was performed using the Statistica
9.1 PL software program. The statistical analyses includ-
ed the means and standard deviations of the data. Sha-
piro-Wilk’s test was used to verify normality, and
Levene’s test was used to verify the homogeneity of
variances. Statistical comparisons were made using the t
test, t test with separate variance estimates, the Mann-
Whitney U test, or the chi-squared test. The Spearman
non-parametric correlation was calculated. A value of
p < 0.05 was considered to be significant.
Table 1 Epidemiologic
parameters and the blood lead
level (PbB), mean, maximum and
minimum PbB, zinc
protoporphyrin concentration in
blood (ZPP) mean, maximum and










Mean SD Mean SD
Age 39.0 11.0 38.0 9.78 −2 0.418
Years of work 13.7 11.4 12.0 10.4 −13 0.157
Height (cm) 176 6.32 176 5.83 0 0.608
Weight (kg) 83.8 14.8 85.4 12.4 2 0.308
Systolic blood pressure (mmHg) 121.91 5.52 121.17 5.42 −1 0.058
Diastolic blood pressure (mmHg) 78.52 4.66 78.09 4.93 −1 0.418
PbB (μg/dl) 33.83 9.43 31.85 9.87 −6 0.030
PbBmean (μg/dl) 32.55 8.86 30.87 9.22 −5 0.069
PbBmin (μg/dl) 20.12 9.71 19.20 9.42 −5 0.397
PbBmax (μg/dl) 43.18 11.47 41.45 12.12 −4 0.087
ZPP (μg/g Hb) 4.28 2.25 4.05 1.90 −5 0.324
ZPPmean (μg/g Hb) 4.81 2.38 4.50 2.26 −6 0.237
ZPPmin (μg/g Hb) 2.87 1.52 2.77 1.19 −4 0.512
ZPPmax (μg/g Hb) 7.89 4.72 7.36 5.00 −7 0.089
ALA (mg/l) 5.38 1.73 4.77 1.95 −11 0.386
PbB and ZPPmean levels of Pb and ZPP in the blood determined simultaneously with the biochemical analysis;
PbBmean and ZPPmean mean levels of Pb and ZPP in the blood calculated based on the values determined, on
average, every 3 months during the 5 years of observation before the study; PbBmin, PbBmax, ZPPmin, and ZPPmax
mean of the maximal and minimal levels of Pb and ZPP in the blood collected from each worker calculated based
on the values determined, on average, every 3 months during the 5 years of observation
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Results
There were no significant differences in age, height, weight,
number of years worked, or smoking habits between the ex-
amined subgroups. The percentages of subjects diagnosed
with coronary artery disease, hypertension, and diabetes did
not differ between the examined subgroups. There was a ten-
dency for the systolic blood pressure to be lower in the H-Se
group compared to that in the L-Se group (p = 0.058), whereas
diastolic blood pressure did not differ between the subgroups
(Tables 1 and 2).
The PbB level was significantly lower in the H-Se group
compared to that in the L-Se group by 6 %. At the same time,
there was a tendency for there to be lower maximal values of
PbB (PbBmax) and ZPP (ZPPmax) and for the PbBmean in the
H-Se group compared to that in the L-Se group. The other Pb-
exposure indices did not differ significantly between the sub-
groups, although the mean values were lower in H-Se group
(Table 1, Fig. 1).
The levels of 8-OHdG and LPS and the SOD activity were
significantly lower in the H-Se group compared to that in the
L-Se group by 17, 19, and 11 %, respectively. However, the
GSH level and activities of GPx and CAT were significantly
higher by 9, 23, and 3 %, respectively (Table 3, Fig. 1).
Spearman correlations showed positive correlations between
the Se level andGPx activity (R = 0.32, p < 0.001), CATactivity
(R = 0.12, p = 0.025), GSH level (R = 0.12, p = 0.035), and LPH
level (R = 0.14, p = 0.013). However, negative correlations were
reported between the Se level and PbB (R = −0.13, p = 0.019),
PbBmean (R = −0.12, p = 0.026), PbBmax (R = −0.14,
p = 0.013), LPS level (R = −0.24, p < 0.001), and SOD activity
(R = −0.24, p < 0.001) (Table 4).
Discussion
The Se concentration in human serum can be divided into
three categories: low Se level below 50–60 μg/l, intermediate
level between 60 and 100 μg/l, and high level above 100–
120 μg/l [28]. In view of this classification, the Se level in
the L-Se group can be classified as rather low (57.9 ± 8.62 μg/
l) and in the H-Se group (90.1 ± 15.6 μg/l) as intermediate.
The results of the present study indicate that lower Se levels
are associated with slightly higher levels of Pb in the blood.
The value of PbB, a short-term marker of exposure, was most
significantly related to the Se level. An inverse relationship
between the levels of Pb and Se was also reported in other
studies. For example, in a study by Kasperczyk et al. [10], a
lower level of Se was reported in Pb-exposed workers com-
pared with that in unexposed controls. Similarly, Gustafson
et al. [29] showed significantly lower plasma Se levels in Pb
smelters than in the control group. There was also a significant
negative correlation between the PbB and plasma Se level in
this study. Additionally, negative correlations between the
levels of Pb and Se were shown in children from urban areas
in Poland [30, 31] and Senegal [32]. The above-mentioned
associations between Pb and Se may be a result of the






Smokers 42 34 0.138
Coronary heart disease 2 3 0.476
Hypertension 9 10 0.711





















Fig. 1 The concentration of
selenium (Se) in serum, blood lead
level (PbB), 8-
hydroxydeoxyguanosine (8-
OHdG) in urine, lipofuscin (LPS)
in erythrocytes, the activity of
glutathione peroxidase (GPx),
catalase (CAT), and superoxide
dismutase (SOD) in erythrocytes
and erythrocyte glutathione (GSH)
concentration expressed as a
percentage of the mean baseline
values in low Se group. Data are
presented as a mean and SEM.
*p < 0.05, **p < 0.01,
***p < 0.001—comparison
between the low and high Se
groups
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formation of inactive Pb-Se complexes (Pb selenide) and al-
terations of the absorption and tissue distribution of Pb by Se
[30, 33].
The antagonistic relationship between Pb and Se has been
confirmed in experimental studies on animals. Optimal doses
of dietary Se were able to partially ameliorate the toxic effects
of Pb in poisoned rats, as estimated by measuring the urine
ALA level and ALAD activity and Pb level in selected tissues
[34]. Moreover, Se was able to mitigate the toxic effects of Pb
on the rat brain [33, 35] and to protect the rat submandibular
gland function from Pb-induced adverse effects, which were
measured by the levels of calcium (Ca) and protein and the
activity of N-acetyl-β-D-glucosaminidase (NAG) in subman-
dibular secretions [35].
The protective effect of Se in Pb poisoning may be due not
only to the above-mentioned mechanisms but also to the re-
duction of oxidative stress through the antioxidant properties
of Se. The decreased level of erythrocyte LPS and increased
level of erythrocyte GSH in the H-Se group compared to that
in the L-Se group support this hypothesis. Moreover, the Se
level was negatively correlated with the LPS level and posi-
tively correlated with the GSH level. It is well documented
that Pb exposure is associated with GSH depletion as a result
of elevated oxidative stress, as well as the accumulation of
LPS, which is composed of cross-linked aggregates of oxi-
dized proteins and lipids [8, 36]. Therefore, the higher level
of GSH and lower level of LPS observed in the H-Se sub-
group can be interpreted as effects of the reduced oxidative
stress and may be due to the simultaneously elevated activity
of GPx in this subgroup. We also observed a significant pos-
itive correlation between the Se level and GPx activity, which
suggests that Se deficiency may significantly diminish the
antioxidant defense. Consistent with our present findings, in
the above-mentioned study on Senegalese children [32], a
positive correlation was also shown between the Se levels
and GPx activity (R = 0.308, p < 0.01).
Nevertheless, we did not observe any positive effects of
higher Se levels on oxidative stress markers measured in the
serum. We showed that there was only a weak positive corre-
lation between the Se level and serum LPH level (R = 0.14).
Moreover, we did not find any significant differences between
the serum values of TAC and TOS and the serum levels of








Mean SD Mean SD
Se (μg/l) in serum 57.9 8.62 90.1 15.6 56 <0.001
TAC (mmol/l) in serum 0.90 0.14 0.92 0.13 3 0.123
TOS (μmol/l) in serum 13.4 15.1 12.0 6.50 −11 0.268
LPH (μmol/l) in serum 4.47 6.07 4.93 3.13 10 0.400
MDA (μmol/l) in serum 2.48 1.06 2.39 1.09 −3 0.469
8OHdG (ng/g creatinine) in urine 13.3 11.73 11.0 7.23 −17 0.039
LPS (RF/dl) in erythrocytes 19.2 9.60 15.6 9.49 −19 <0.001
GPx (U/gHb) in erythrocytes 51.2 27.37 62.9 26.8 23 <0.001
GR (U/g Hb) in erythrocytes 4.59 1.94 4.51 1.63 −2 0.671
CAT (kU/g Hb) in erythrocytes 435 59.0 450 57.4 3 0.023
SOD (NU/mg Hb) in erythrocytes 10.6 2.68 9.40 2.37 −11 <0.001
GSH (μmol/g Hb) in erythrocytes 3.44 1.09 3.75 1.16 9 0.006
Table 4 Correlations
between selenium and










in blood and urine
(Spearman R coefficient)
R p value
Se and PbB −0.13 0.019
Se and PbBmean −0.12 0.026
Se and PbBmin −0.09 0.113
Se and PbBmax −0.14 0.013
Se and ZPP −0.02 0.768
Se and ZPPmean −0.08 0.172
Se and ZPPmax −0.09 0.110
Se and ZPPmin −0.03 0.573
Se and TAC 0.07 0.185
Se and TOS −0.02 0.721
Se and LPH 0.14 0.013
Se and MDA −0.07 0.197
Se and LPS −0.24 <0.001
Se and 8OHdG −0.09 0.111
Se and GPx 0.32 <0.001
Se and GR 0.04 0.447
Se and CAT 0.12 0.025
Se and SOD −0.24 <0.001
Se and GSH 0.12 0.035
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MDA and LPH between the examined subgroups. These re-
sults suggest that the bioavailability of Se and its protective
effects may be higher in erythrocytes than in serum. This hy-
pothesis is supported by a previous in vitro study showing that
the presence of Pb results in the accumulation of Se in eryth-
rocytes [37]. The authors of that study postulated the existence
of a protein that simultaneously binds Pb and Se in erythro-
cytes. Supporting that previous study, Chiba et al. [38] showed
that the plasma Se level had a tendency to decrease, whereas its
concentration in erythrocytes increased significantly, with an
increasing blood Pb level in Pb-exposed workers.
The interactions among the Pb and Se levels and activities
of SOD, CAT, and GR are more difficult to interpret. The
accumulated data suggest that Pb may trigger opposing mech-
anisms influencing antioxidant enzyme activities. These com-
plex interactions likely resulted in the divergent results of
studies on this topic [9]. In a study by Kasperczyk et al. [9]
conducted on Pb-exposed workers, it was shown that Pb ex-
posure induced the expression and activity of SOD as a result
of a compensatory defense mechanism against oxidative
stress. In light of this finding, the lower level of SOD in the
H-Se subgroup compared to that in the L-Se subgroup may be
due to a lower intensity of oxidative stress due to the simulta-
neously elevated activity of GPx and CAT.
The results of the present study are generally supported by
other studies. Li et al. [39] showed that Se has protective
activities against Pb-induced neurotoxicity in Caenorhabditis
elegans through its ability to decrease ROS production. Sodi-
um selenite was reported to alleviate oxidative stress injury, as
measured by the MDA level induced by Pb exposure, in rats
[40]. In other study on rats, Se administration decreased lipid
peroxidation in the liver and kidney cells by increasing the
activities of the superoxide dismutase and glutathione reduc-
tase and the glutathione content [41]. The results of studies on
Pb-poisoned fish also confirmed the beneficial effects of Se
administration of Pb toxicity [1, 42, 43].
The lower level of urine 8-OHdG in the H-Se subgroup
compared to that in the L-Se subgroup in the present study
may also be associated with reduced oxidative stress in sub-
jects with higher Se levels. Lead exposure has been linked to
elevated DNA damage, including oxidative damage [44]. 8-
OHdG is one of the markers of oxidative DNA damage [45],
and its lower levels in the H-Se subgroup may be a result of
elevated activity of GPx. However, many other mechanisms
may be involved, including the influence of Se on DNA repair
[46]. Consistent with this possibility, an experimental study on
mice reported that the negative effects of Pb on the DNA
structure measured in a comet assay were alleviated by the
administration of Se [47].
Many studies have shown that Pb can significantly increase
arterial blood pressure. This increase may be caused by the
influence of ROS on the metabolism of the endothelium and
other cells of the circulatory system under Pb-induced
oxidative stress conditions [48, 49]. This hypothesis is sup-
ported by a study on Pb-exposed workers, which showed that
the arterial blood pressure (both systolic and diastolic) was
positively correlated with the MDA and Pb levels and nega-
tively correlated with the GPx activity [49]. These results are
in agreement with the present findings, because the L-Se sub-
group had a tendency to have higher systolic blood pressure
compared to the H-Se subgroup. However, data on the asso-
ciations between the Se level and blood pressure are still in-
conclusive, and larger-scale studies are needed to clarify these
associations [50].
Conclusions
A lower serum Se level in chronically Pb-exposed subjects is
associated with higher Pb blood levels and an elevated eryth-
rocyte LPS level, which reflects the intensity of oxidative
stress. Besides, in a group of Pb-exposed subjects with lower
serum Se level, depleted GSH pool and decreased activity of
GPx in erythrocytes were reported. However, the present re-
sults are inadequate to recommend Se supplementation for
chronic lead exposure at higher doses than would be included
in a normal diet except for selenium deficiency.
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